000 01835 a2200529 4500
005 20250515223852.0
264 0 _c20100916
008 201009s 0 0 eng d
022 _a1538-8514
024 7 _a10.1158/1535-7163.MCT-09-1173
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMunshi, Neru
245 0 0 _aARQ 197, a novel and selective inhibitor of the human c-Met receptor tyrosine kinase with antitumor activity.
_h[electronic resource]
260 _bMolecular cancer therapeutics
_cJun 2010
300 _a1544-53 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCaspases
_xmetabolism
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aHumans
650 0 4 _aImmunosuppression Therapy
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aNeoplasms
_xenzymology
650 0 4 _aPhosphorylation
_xdrug effects
650 0 4 _aProtein Kinase Inhibitors
_xchemistry
650 0 4 _aProto-Oncogene Mas
650 0 4 _aProto-Oncogene Proteins c-met
_xantagonists & inhibitors
650 0 4 _aPyrroles
_xchemistry
650 0 4 _aPyrrolidinones
_xchemistry
650 0 4 _aQuinolines
_xchemistry
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aJeay, Sébastien
700 1 _aLi, Youzhi
700 1 _aChen, Chang-Rung
700 1 _aFrance, Dennis S
700 1 _aAshwell, Mark A
700 1 _aHill, Jason
700 1 _aMoussa, Magdi M
700 1 _aLeggett, David S
700 1 _aLi, Chiang J
773 0 _tMolecular cancer therapeutics
_gvol. 9
_gno. 6
_gp. 1544-53
856 4 0 _uhttps://doi.org/10.1158/1535-7163.MCT-09-1173
_zAvailable from publisher's website
999 _c19837816
_d19837816